Ms. Elizabeth  Shea

Vice President of Investor Relations

Ms. Rae L. Livingston

Chief Equity Officer

Mr. Jeffrey Ryan Stewart

Executive Vice President & Chief Commercial Officer

Mr. Robert A. Michael

Vice Chairman & Pres

Dr. Azita  Saleki-Gerhardt Ph.D.

Executive Vice President of Operations

Mr. Scott T. Reents

Senior Vice President & Chief Financial Officer

Mr. Richard A. Gonzalez

Chairman & Chief Executive Officer

Dr. Thomas J. Hudson

Senior Vice President of R&D and Chief Scientific Officer

Executive Vice President & Chief Financial Officer

Mr. Perry C. Siatis

Executive Vice President, Gen. Counsel & Sec.

Mr. Timothy J. Richmond

Executive Vice President & Chief HR Officer

Ms. Laura J. Schumacher

Vice Chairman of External Affairs & Chief Legal Officer

Dr. Thomas J. Hudson M.D.

Dr. Nicholas R. Donoghoe M.D.

Senior Vice President of R&D and Chief Operating Officer

Ms. Tracie  Haas

Senior Vice President of Corporation Responsibility, Brand & Communications

Dr. Thomas  Hudson M.D.

Ms. Carrie C. Strom

Senior Vice President of AbbVie & Pres of Global Allergan Aesthetics

Mr. Henry O. Gosebruch

Executive Vice President & Chief Strategy Officer

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

This article discusses three high-yielding stocks for retirees and income-oriented investors: ONEOK, AbbVie, and Realty Income. ONEOK is a cyclical income play with a 6.5% yield, AbbVie offers a high-quality healthcare yield of 4.2%, and Realty Income provides steady and reliable dividend growth with a 5.2% yield.

Buy Alert: 3 Undervalued High-Yield Gems For Your Retirement

Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices.

Should You Pick AbbVie Stock Over LLY?

The best retirement stocks ideally have high dividend yields that can be sustained. This can lead to steady income and long-term value for retirees.

Best Retirement Stocks to Buy Now

AbbVie's Humira now faces competition from biosimilars, but things look more promising in the long run. 3M's margins have been shrinking, but its biggest risk is the plethora of lawsuits relating to its earplugs.

2 Dividend Kings on Sale That Are Yielding More Than 4%

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields - CVS Health (NYSE:CVS), AbbVie (NYSE:ABBV)

Powered by AI

AbbVie Inc.

137.56